NCT06308406 2024-04-11
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
231 trialsNCT05143970 2024-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Unknown
NCT04780217 2024-03-04
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
NCT04512209 2024-02-28
DCE-MRI
University Hospital, Ghent
Phase NA Unknown
NCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT04145388 2024-02-14
Family History Study on Cancer Risk
Kaiser Permanente
Phase NA Unknown
NCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT06250686 2024-02-09
BENITA
Universitätsklinikum Hamburg-Eppendorf
Phase NA Unknown
NCT06243185 2024-02-06
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
Peking Union Medical College Hospital
Phase 2 Unknown
NCT06241105 2024-02-05
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02489006 2024-01-17
NEO
University Health Network, Toronto
Phase 2 Unknown
NCT05065021 2024-01-17
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
University Health Network, Toronto
Phase 2 Unknown
NCT06161272 2023-12-07
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Guangxi Medical University
Phase 2 Unknown
NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
NCT05048407 2023-11-18
Sirius in Gynaecological Laparoscopic Surgery
Precision Robotics (Hong Kong) Limited
Phase NA Unknown
NCT05960630 2023-11-18
MIRRORS-RCTP
Royal Surrey County Hospital NHS Foundation Trust
Phase NA Unknown
NCT02584478 2023-11-08
AL3818
Advenchen Laboratories, LLC
Phase 3 Unknown
NCT05498597 2023-10-19
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Phase 1 Unknown
NCT04938583 2023-10-17
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
CanariaBio Inc.
Phase 1/2 Unknown
NCT05272462 2023-10-05
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
Loyola University
Phase 2 Unknown
NCT06065358 2023-10-03
TOSCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT03382340 2023-09-28
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
Phase 1/2 Unknown
NCT05420545 2023-08-18
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Chongqing Precision Biotech Co., Ltd
Phase 1 Unknown
NCT05468190 2023-08-18
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
Phase 1 Unknown
NCT03363867 2023-08-07
BEACON
Peter MacCallum Cancer Centre, Australia
Phase 2 Unknown
NCT05979298 2023-08-07
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
CureLab Oncology
Phase 2 Unknown
NCT05318625 2023-08-03
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
Precision Robotics (Hong Kong) Limited
Phase NA Unknown
NCT05585281 2023-07-28
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT05965141 2023-07-28
Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05749211 2023-05-16
Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer
Ruijin Hospital
Phase NA Unknown
NCT05430906 2023-04-25
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
Hunan Cancer Hospital
Phase 2 Unknown
NCT05819060 2023-04-19
The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab
Fudan University
Phase 2 Unknown
NCT05801783 2023-04-06
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05776355 2023-03-28
NKG2D CAR-NK & Ovarian Cancer
Hangzhou Cheetah Cell Therapeutics Co., Ltd
Phase NA Unknown
NCT00326456 2023-03-27
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
National Cancer Institute, Naples
Phase 3 Unknown
NCT00660842 2023-03-24
MITO-7
National Cancer Institute, Naples
Phase 3 Unknown
NCT01706120 2023-03-24
MITO16/MANGO-2
National Cancer Institute, Naples
Phase 4 Unknown
NCT01802749 2023-03-24
MITO16MANGO2b
National Cancer Institute, Naples
Phase 3 Unknown
NCT03410784 2023-03-24
MITO28MaNGOov4
National Cancer Institute, Naples
Phase 2 Unknown
NCT04091204 2023-03-24
MITO 31
National Cancer Institute, Naples
Phase 2 Unknown
NCT05233982 2023-03-24
MITO 35a
National Cancer Institute, Naples
Phase 2 Unknown
NCT05769205 2023-03-15
MRI in Ovarian Tumors
Assiut University
Phase NA Unknown
NCT05184140 2023-03-07
MELISA
Hospital Clinic of Barcelona
Phase NA Unknown
NCT04768868 2023-02-24
WEE1
Impact Therapeutics, Inc.
Phase 1 Unknown
NCT03321188 2023-02-06
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
Phase 2 Unknown
NCT05453825 2023-01-31
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
OncXerna Theraputics, Inc.
Phase 2 Unknown
NCT03430700 2023-01-30
PROMPT
University College, London
Phase 2 Unknown